Suppr超能文献

在糖尿病肾病早期,高血糖通过SGLT2和p21依赖性途径导致近端肾小管细胞衰老。

Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.

作者信息

Kitada Kento, Nakano Daisuke, Ohsaki Hiroyuki, Hitomi Hirofumi, Minamino Tohru, Yatabe Junichi, Felder Robin A, Mori Hirohito, Masaki Tsutomu, Kobori Hiroyuki, Nishiyama Akira

机构信息

Department of Pharmacology, Kagawa University, Kagawa, Japan.

Department of Pharmacology, Kagawa University, Kagawa, Japan.

出版信息

J Diabetes Complications. 2014 Sep-Oct;28(5):604-11. doi: 10.1016/j.jdiacomp.2014.05.010. Epub 2014 Jun 4.

Abstract

AIMS

Kidney cells in patients with diabetic nephropathy are reported to be senescent. However, the mechanisms that regulate cellular senescence in the diabetic kidney are still unknown. In the present study, we evaluated the contribution of high glucose to renal cell senescence in streptozotocin (STZ)-induced diabetic mice.

METHODS

Non-diabetic and streptozotocin (STZ, 10mgkg(-1)day(-1) for 7days, i.p.)-induced type 1 diabetic C57BL/6J mice and cultured human proximal tubular cells were used in this study.

RESULTS

Hyperglycemia dramatically increased the renal expression of p21 but not other CDK inhibitors such as p16 and p27 at 4weeks after STZ injection. These changes were accompanied by an increase in senescence-associated β-galactosidase staining in tubular epithelial cells. Administration of insulin at doses that maintained normoglycemia or mild hypoglycemia suppressed the changes induced by STZ. Insulin did not affect the senescent markers in non-diabetic mice. Exposure of cultured human proximal tubular cells to 25mmol/L, but not 8mmol/L, glucose medium increased the expression of senescence markers, which was suppressed by knock-down of p21 or sodium glucose cotransporter (SGLT) 2.

CONCLUSIONS

These results suggest that hyperglycemia causes tubular senescence via a SGLT2- and p21-dependent pathway in the type 1 diabetic kidney.

摘要

目的

据报道,糖尿病肾病患者的肾细胞会发生衰老。然而,调节糖尿病肾脏细胞衰老的机制仍不清楚。在本研究中,我们评估了高糖对链脲佐菌素(STZ)诱导的糖尿病小鼠肾细胞衰老的影响。

方法

本研究使用非糖尿病和链脲佐菌素(STZ,10mgkg⁻¹天⁻¹,腹腔注射,共7天)诱导的1型糖尿病C57BL/6J小鼠以及培养的人近端肾小管细胞。

结果

STZ注射后4周,高血糖显著增加了肾脏中p21的表达,但未增加其他细胞周期蛋白依赖性激酶抑制剂如p16和p27的表达。这些变化伴随着肾小管上皮细胞中衰老相关β-半乳糖苷酶染色的增加。给予维持正常血糖或轻度低血糖水平的胰岛素剂量可抑制STZ诱导的变化。胰岛素对非糖尿病小鼠的衰老标志物没有影响。将培养的人近端肾小管细胞暴露于25mmol/L而非8mmol/L的葡萄糖培养基中会增加衰老标志物的表达,这种增加可通过敲低p21或钠-葡萄糖协同转运蛋白(SGLT)2来抑制。

结论

这些结果表明,高血糖通过SGLT2和p21依赖性途径导致1型糖尿病肾脏中的肾小管衰老。

相似文献

1
Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.
J Diabetes Complications. 2014 Sep-Oct;28(5):604-11. doi: 10.1016/j.jdiacomp.2014.05.010. Epub 2014 Jun 4.
4
Effect of renal tubule-specific knockdown of the Na/H exchanger NHE3 in Akita diabetic mice.
Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F419-F434. doi: 10.1152/ajprenal.00497.2018. Epub 2019 Jun 5.
5
Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
Am J Kidney Dis. 2014 Jul;64(1):16-24. doi: 10.1053/j.ajkd.2014.02.010. Epub 2014 Mar 25.
6
Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.
Am J Physiol Renal Physiol. 2013 Jan 15;304(2):F156-67. doi: 10.1152/ajprenal.00409.2012. Epub 2012 Nov 14.
7
NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney.
Free Radic Biol Med. 2015 Jun;83:21-30. doi: 10.1016/j.freeradbiomed.2015.02.009. Epub 2015 Feb 18.
8
Chelation of dietary iron prevents iron accumulation and macrophage infiltration in the type I diabetic kidney.
Eur J Pharmacol. 2015 Jun 5;756:85-91. doi: 10.1016/j.ejphar.2015.03.053. Epub 2015 Mar 26.
9
Preventive effect of Shenkang injection against high glucose-induced senescence of renal tubular cells.
Front Med. 2019 Apr;13(2):267-276. doi: 10.1007/s11684-017-0586-8. Epub 2018 Apr 25.

引用本文的文献

1
The Role of Renal Cell Senescence in Diabetic Kidney Disease: Mechanisms and Therapeutic Advances.
Diabetes Metab Syndr Obes. 2025 Sep 8;18:3323-3341. doi: 10.2147/DMSO.S543814. eCollection 2025.
2
SGLT2 inhibitors as a novel senotherapeutic approach.
NPJ Aging. 2025 May 10;11(1):35. doi: 10.1038/s41514-025-00227-y.
4
The Role of Mitochondria in Diabetic Kidney Disease and Potential Therapeutic Targets.
Kidney Int Rep. 2024 Nov 9;10(2):328-342. doi: 10.1016/j.ekir.2024.10.035. eCollection 2025 Feb.
5
Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective.
Front Med. 2025 Apr;19(2):200-225. doi: 10.1007/s11684-024-1116-0. Epub 2025 Jan 17.
7
mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes.
Int J Mol Sci. 2024 Aug 8;25(16):8676. doi: 10.3390/ijms25168676.
8
T-Cell Senescence in Human Metabolic Diseases.
Diabetes Metab J. 2024 Sep;48(5):864-881. doi: 10.4093/dmj.2024.0140. Epub 2024 Aug 28.
9
A nutrigeroscience approach: Dietary macronutrients and cellular senescence.
Cell Metab. 2024 Sep 3;36(9):1914-1944. doi: 10.1016/j.cmet.2024.07.025. Epub 2024 Aug 22.
10
Biology of the proximal tubule in body homeostasis and kidney disease.
Nephrol Dial Transplant. 2025 Feb 4;40(2):234-243. doi: 10.1093/ndt/gfae177.

本文引用的文献

1
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.
Nature. 2013 Jul 4;499(7456):97-101. doi: 10.1038/nature12347. Epub 2013 Jun 26.
2
High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway.
PLoS One. 2013;8(1):e54514. doi: 10.1371/journal.pone.0054514. Epub 2013 Jan 16.
3
Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.
Am J Physiol Renal Physiol. 2013 Jan 15;304(2):F156-67. doi: 10.1152/ajprenal.00409.2012. Epub 2012 Nov 14.
6
Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor.
Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):257-63. doi: 10.1161/ATVBAHA.111.240697. Epub 2011 Dec 15.
8
Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells.
Am J Hypertens. 2011 Oct;24(10):1149-55. doi: 10.1038/ajh.2011.114. Epub 2011 Jun 30.
9
NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway.
Cell Physiol Biochem. 2011;27(6):681-90. doi: 10.1159/000330077. Epub 2011 Jun 17.
10
SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53.
Am J Physiol Renal Physiol. 2011 Aug;301(2):F427-35. doi: 10.1152/ajprenal.00258.2010. Epub 2011 May 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验